We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
AUM
$294M
AUM Growth
-$9.85M
Cap. Flow
+$1.77M
Cap. Flow %
0.6%
Top 10 Hldgs %
39.32%
Holding
79
New
1
Increased
20
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
KR icon
Kroger
KR
+$2.02M
2
CELG
Celgene Corp
CELG
+$768K
3
INTC icon
Intel
INTC
+$486K
4
BIIB icon
Biogen
BIIB
+$153K
5
GE icon
GE Aerospace
GE
+$106K

Top Sells

Rank Stock Value
1
BIVV
Bioverativ Inc. Common Stock
BIVV
+$892K
2
PPG icon
PPG Industries
PPG
+$684K
3
ING icon
ING
ING
+$376K
4
FLS icon
Flowserve
FLS
+$78.4K
5
WWD icon
Woodward
WWD
+$60.2K

Sector Composition

Rank Sector Weight
1 Healthcare 27.28%
2 Industrials 22.33%
3 Technology 18.33%
4 Consumer Staples 8.63%
5 Energy 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBT icon
76
Cabot Corp
CBT
$4.52B
$267K 0.09%
4,800
LEG icon
77
Leggett & Platt
LEG
$1.31B
$244K 0.08%
5,500
ING icon
78
ING
ING
$102B
-20,388
Closed -$376K
BIVV
79
DELISTED
Bioverativ Inc. Common Stock
BIVV
-16,538
Closed -$892K

Similar funds

Thompson Rubinstein Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Thompson Rubinstein Investment Management held 79 positions worth $294M, down 3.2% from $304M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 3.8%. Thompson Rubinstein Investment Management opened 1 new position and exited 2, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q1 2018 buy was Kroger: 74,507 shares worth $1.78M.
  • Thompson Rubinstein Investment Management added most to Celgene Corp in Q1 2018, an estimated $768K increase.
  • Thompson Rubinstein Investment Management's biggest Q1 2018 reduction was PPG Industries, cutting an estimated $684K.
  • Thompson Rubinstein Investment Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $892K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 39% of its $294M portfolio in Q1 2018.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 2 in Q1 2018.
  • Thompson Rubinstein Investment Management's portfolio value fell 3.2% quarter-over-quarter to $294M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2018, filed 6 Apr 2018.